AMPLATZER Duct Occluder II Additional Sizes
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03055858
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT03055858
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03055858. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-05 (actual); primary completion 2019-09-25 (actual). Results posted on 2020-10-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AMPLATZER Duct Occluder II Additional Sizes
- Acronym
- ADO II AS
- Condition
- Patent Ductus Arteriosus
- Intervention (Device)
- ADO II AS (PDA closure)
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03055858- Content hash
19fb927ffb723e915f9abb7fd6a69dcaa89784041811787233d788f2f00ba5e1